ucsf logo

Xiaokun Shu receives NIH New Innovator Award to study protein interactions

Xiaokun Shu

Xiaokun Shu, PhD - Image: ©majedphoto.com

Xiaokun Shu, PhD, has been named a recipient of the 2012 National Institutes of Health (NIH) Director’s New Innovator award, which will provide up to $1.5 million in research funding over the next five years.

Shu, a faculty member in the UCSF School of Pharmacy’s Department of Pharmaceutical Chemistry, will use the funding to develop a new technology to identify dynamic interactions between proteins in human cells.

In particular, Shu’s NIH-funded work will seek to detect weakly binding and short-lived interactions that can be difficult to detect via current techniques but which can play vital roles in health and disease.

More: Xiaokun Shu receives NIH New Innovator Award to study protein interactions

Tags: 
NIH
Protein Interactions
New Innovator Award
Key people: 
Xiaokun Shu

Next topic: About QBC